FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称PEMIVIBART
异名/同义词IMMUNOGLOBULIN G1 (435-LEUCINE,441-ALANINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL VYD222 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VYD222 .LAMBDA.2-CHAIN, DIMER
IMMUNOGLOBULIN G1-LAMBDA2, ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY
PEMIVIBART
PEMIVIBART [INN]
PEMIVIBART [WHO-DD]
CAS登记号2858673-18-2
物质唯一标识(Unique Ingredient Identifier)557S3L3FAP
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / protein
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System